title: Facial hyperpigmentation: causes and treatment.
abstract: By midcentury, the U.S.A. will be more ethnically and racially diverse. Skin of colour will soon constitute nearly one-half of the U.S. population, and a full understanding of skin conditions that affect this group is of great importance. Structural and functional differences in the skin, as well as the influence of cultural practices, produce variances in skin disease and presentation based on skin type. In the skin of colour population, dyschromia is a growing concern, and a top chief complaint when patients present to the physician. A thorough understanding of the aetiology and management strategies of facial hyperpigmentation is of importance in caring for those afflicted and also in the development of new therapies.
authors.affiliation: Department of Dermatology, Boston University School of Medicine, Boston Medical Center, 609 Albany St, J602, Boston, MA, 02118, U.S.A.
authors.forename: N A
authors.initials: NA
authors.lastname: Vashi
authors.forename: R V
authors.initials: RV
authors.lastname: Kundu
mesh_terms: D000279:Administration, Cutaneous; D018354:Alphavirus Infections / Q000150:complications / Q000208:ethnology; D065632:Chikungunya Fever; D003869:Dermabrasion / Q000379:methods; D003879:Dermatologic Agents / Q000627:therapeutic use; D004338:Drug Combinations; D005148:Facial Dermatoses / Q000208:ethnology / Q000209:etiology* / Q000628:therapy; D006801:Humans; D017495:Hyperpigmentation / Q000208:ethnology / Q000209:etiology* / Q000628:therapy; D053685:Laser Therapy / Q000379:methods; D008010:Lichen Planus / Q000150:complications / Q000208:ethnology / Q000628:therapy; D009506:Nevus / Q000150:complications / Q000208:ethnology / Q000628:therapy; D009794:Ochronosis / Q000150:complications / Q000208:ethnology / Q000628:therapy; D012878:Skin Neoplasms / Q000150:complications / Q000208:ethnology / Q000628:therapy
chemical_list: D003879:Dermatologic Agents; D004338:Drug Combinations